Devroe Eric (CIK 0001950573)

Latest company ownership

Shares held
65,308
Last filed at
Nov 18, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 14, 2025 Nov 18, 2025 Acrivon Therapeutics, Inc. COO Sell 50.0 -613 -0.93% ✗ $1.4K
Aug 14, 2025 Aug 18, 2025 Acrivon Therapeutics, Inc. COO Sell 50.0 -613 -0.92% ✗ $852.1
May 14, 2025 May 16, 2025 Acrivon Therapeutics, Inc. COO Sell 50.0 -613 -0.91% ✗ $698.8
Feb 14, 2025 Feb 19, 2025 Acrivon Therapeutics, Inc. COO Sell 47.5 -724 -1.07% ✗ $3.9K
Nov 14, 2024 Nov 18, 2024 Acrivon Therapeutics, Inc. COO Sell 50.0 -613 -0.90% ✗ $4.9K
Aug 14, 2024 Aug 16, 2024 Acrivon Therapeutics, Inc. COO Sell 50.0 -613 -0.89% ✗ $4.3K
May 14, 2024 May 16, 2024 Acrivon Therapeutics, Inc. COO Sell 47.5 -613 -1.03% ✗ $5.1K
Feb 14, 2024 Feb 16, 2024 Acrivon Therapeutics, Inc. COO Sell 47.5 -723 -1.20% ✗ $2.5K
Nov 14, 2023 Nov 16, 2023 Acrivon Therapeutics, Inc. COO Sell 46.3 -2,450 -3.90% ✗ $12.4K